Eu2P - European programme in Pharmacovigilance and Pharmacoepidemiology
Pharmaceuticals - Bordeaux, Nouvelle-Aquitaine, France
Eu2P - European programme in Pharmacovigilance and Pharmacoepidemiology Employees
Eu2P - European programme in Pharmacovigilance and Pharmacoepidemiology Details
Eu2P is a European online education and training programme in pharmacovigilance and pharmacoepidemiology that delivers Master and PhD diplomas, and on-the-job training continuing education certificates or short courses.Eu2P is a unique partnership of seven Universities, fifteen pharmaceutical companies, the French and the European medicines agencies. Eu2P is funded by the EU and the EFPIA through the Innovative Medicines Initiative.- Eu2P academic partnersUniversité Bordeaux Segalen - FranceErasmus Universitair Medisch Centrum - The NetherlandsFundació Institut Catalá de Farmacologia - Universitat Autonoma de Barcelona - SpainUniversity of Hertfordshire - United KingdomUniversita di Verona - ItalyUtrecht Universiteit - The NetherlandsKarolinska Institutet - Sweden- Eu2P regulatory partnersEMA (European Medicines Agency) - United KingdomANSM (Agence nationale de sécurité du médicament et des produits de santé) - France- Eu2P industrial partnersF. Hoffmann-La Roche Ltd - SwitzerlandAmgen NV - BelgiumAstraZeneca AB - United KingdomBayer HealthCare - GermanyBoehringer Ingelheim International GmbH - GermanyEli Lilly and Company Limited - United KingdomGlaxoSmithKline Research and Development Ltd - United KingdomH. Lundbeck A/S - DenmarkJanssen Pharmaceutica NV - BelgiumLaboratorios Almirall SA - SpainNovartis Pharma AG - SwitzerlandNovo Nordisk A/S - DenmarkOrion Corporation - FinlandSanofi-aventis Recherche et Développement - FranceUCB Pharma SA - Belgium
Eu2P - European programme in Pharmacovigilance and Pharmacoepidemiology Technologies
Captcha
reCAPTCHA
Load Balancers
Apache
SSL Certificates
OpenSSL
Analytics and Tracking
Google Analytics
Online Video Platforms
YouTube